Inhibition of caffeine metabolism by estrogen replacement therapy in postmenopausal women

Journal of Clinical Pharmacology

Volumn 39, Issue 9, 1999, Pages 936-940

  Pollock, B G ^a   Wylie, M ^a   Stack, J A ^a   Sorisio, D A ^a   Thompson, D S ^a   Kirshner, M A ^a   Folan, M M ^a   Condifer, K A ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAFFEINE; CYTOCHROME P450; ESTRADIOL; ESTROGEN;

ADULT; AGED; ARTICLE; DRUG BLOOD LEVEL; ESTROGEN THERAPY; FEMALE; HUMAN; HUMAN EXPERIMENT; METABOLISM; NORMAL HUMAN; POSTMENOPAUSE;

EID: 0033341632     PISSN: 00912700     EISSN: None     Source Type: Journal    
DOI: 10.1177/00912709922008560     Document Type: Article

References (21)

1. Drug interactions
2. P450 enzymes of estrogen metabolism
3. Role of human hepatic cytochrome P450 1A2 and 3A4 in the metabolic activation of estrone
4. Interindividual variations in human liver cytochrome P450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: Studies with liver microsomes of 30 Japanese and 30 Caucasians
5. Menstrual cycle effects on caffeine elimination in the human female
6. Influence of the menstrual cycle on theophylline pharmacokinetics in asthmatics
7. Simple and reliable CYP1A2 phenotyping by the paraxanthine/caffeine ratio in plasma and in saliva
8. Disposition of caffeine and its metabolism in man
9. Inhibition of oral contraceptive steroid-metabolizing enzymes by steroids and drugs
10. Impaired elimination of caffeine by oral contraceptive steroids
11. Comparison of caffeine metabolism in three nonsmoking populations after oral administration of radio-labeled caffeine
12. Rapid onset of an increase in caffeine residence time in young women due to oral contraceptive steroids
13. Functional role of estrogen metabolism in target cells: Review and perspectives
14. Failure of caffeine to affect metabolism during 60 min submaximal exercise
15. A simple useful method for the determination of hepatic function in patients with liver cirrhosis using caffeine and its three major dimethylmetabolites
16. The disposition of caffeine during and after pregnancy
17. Impairment of caffeine clearance by chronic use of low-dose oestrogen-containing oral contraceptives
18. Inhibition of antide-pressant demethylation and hydroxylation by fluvoxamine in depressed patients
19. Effects of estrogen replacement therapy on response to tacrine in patients with Alzheimer's disease
20. Caffeine as a metabolic probe: A comparison of the metabolic ratios used to assess CYP1A2 activity
21. Estrogen replacement in postmenopausal women: Are we currently overdosing our patients?